Top Markets
#1 Bedrock Bedrock +54.89%
#2 Naoris Protocol Naoris Protocol +20.56%
#3 IQ IQ +19.64%
#4 pippin pippin +18.04%
#5 Irys Irys +17.34%
#6 パンチ (Punch) パンチ (Punch) +13.44%
#7 ETHGas ETHGas +13.37%
#8 Bitway Bitway +12.92%
#9 Magma Finance Magma Finance +12.90%
#10 Aria.AI Aria.AI +12.61%
Coin of the day
Bedrock Bedrock
設定
言語
日本
通貨
USD
テーマ
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
株式のランク #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
株価
$0.16328419
時価総額
$204.14K
変化（1日）
4.35%
変化（1年）
102.45%
国
GB
取引 Fusion Antibodies plc (FAB)

カテゴリー

Healthcare
Fusion Antibodies plc（FAB）の配当利回りの履歴
Fusion Antibodies plc（銘柄コード: FAB）の配当利回り（TTM）は2024-03-31時点で0.00%です。
過去5年間の平均配当利回り: 0.00%
Fusion Antibodies plc（FAB）の2013から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
2026 (TTM) 0.00% 0.00%
2025 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
4.72%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
0.48%
US
UCB SA UCB SA
UCB SA
UCB.BR
0.48%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL